MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 120 filers reported holding MAXCYTE INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $51,262 | +602.3% | 13,077 | +650.7% | 0.00% | – |
| Q1 2024 | $7,299 | -96.1% | 1,742 | -95.6% | 0.00% | -100.0% |
| Q4 2023 | $187,972 | +1905.5% | 39,994 | +1231.4% | 0.00% | – |
| Q3 2023 | $9,373 | -71.5% | 3,004 | -58.0% | 0.00% | -100.0% |
| Q2 2023 | $32,850 | +93757.1% | 7,157 | +0.7% | 0.00% | 0.0% |
| Q1 2023 | $35 | +118.8% | 7,108 | +139.8% | 0.00% | 0.0% |
| Q4 2022 | $16 | -100.0% | 2,964 | -85.7% | 0.00% | -50.0% |
| Q3 2022 | $134,000 | +458.3% | 20,676 | +305.2% | 0.00% | +100.0% |
| Q2 2022 | $24,000 | +166.7% | 5,103 | +260.9% | 0.00% | – |
| Q1 2022 | $9,000 | -72.7% | 1,414 | -57.1% | 0.00% | -100.0% |
| Q4 2021 | $33,000 | -67.0% | 3,298 | -59.9% | 0.00% | -66.7% |
| Q3 2021 | $100,000 | – | 8,216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $20,963,000 | 8.46% |
| NORTH RUN CAPITAL, LP | 556,960 | $3,620,000 | 7.35% |
| Vitruvian Partners LLP | 5,043,356 | $32,782,000 | 5.85% |
| Casdin Capital, LLC | 10,735,786 | $69,783,000 | 4.58% |
| RIVER GLOBAL INVESTORS LLP | 1,867,113 | $11,880,000 | 2.28% |
| APIS CAPITAL ADVISORS, LLC | 200,000 | $1,300,000 | 1.95% |
| Pier Capital, LLC | 1,262,654 | $8,207,000 | 1.41% |
| Montanaro Asset Management Ltd | 929,000 | $6,009,000 | 0.92% |
| First Light Asset Management, LLC | 1,362,543 | $8,857,000 | 0.90% |
| Grandeur Peak Global Advisors, LLC | 1,206,013 | $7,839,000 | 0.48% |